Advertisement

Investigation of Neuregulin-1 and Glial Cell-Derived Neurotrophic Factor in Rodent Astrocytes and Microglia

  • Jessica Kronenberg
  • Lukas Merkel
  • Sandra Heckers
  • Viktoria Gudi
  • H. Markus Schwab
  • Martin StangelEmail author
Article
  • 47 Downloads

Abstract

Growth factors play a crucial role during de- and remyelination of the central nervous system (CNS) due to their neurotrophic functions. We have previously shown that the growth factors neuregulin-1 (Nrg-1) and glial cell-derived neurotrophic factor (Gdnf) are upregulated during the first 2 weeks after induction of toxic demyelination in the CNS. Nevertheless, the factors responsible for Nrg-1/Gdnf upregulation and their effects on glia cells are unknown. We investigated the effect on Nrg-1 and Gdnf expressions after stimulation of primary mouse microglia or astrocytes with various pro- and anti-inflammatory factors. Additionally, primary cells were incubated with NRG-1 and/or GDNF followed by determining the gene expression level of their receptors, chemokines, and other growth factors. We demonstrate that inflammatory stimuli have a distinct impact on the expression of Gdnf, Nrg-1, and their receptors in astrocytes and microglia. In microglia, LPS or simultaneous treatment with IFNγ plus TNFα led to downregulation of Nrg-1, whereas LPS treatment slightly increased Nrg-1 expression in astrocytes. Furthermore, Gdnf was slightly upregulated after TFG-β treatment in microglia, while Gdnf was significantly upregulated after LPS treatment in astrocytes. In contrast, treatment with GDNF or/and NRG-1 did not alter any measured gene expression in microglia or astrocytes. Taken together, our in vitro studies show that Nrg-1, Gdnf, and their receptors are differently regulated in astrocytes and microglia upon inflammatory stimuli. The lack of response of astrocytes and microglia to NRG-1 and GDNF suggests that both factors exert their effects directly on neurons.

Keywords

Neuregulin-1 Glial cell-derived neurotrophic factor Astrocytes Microglia Multiple sclerosis 

Notes

Acknowledgements

The authors thank I. Cierpka-Leja and S. Lang for excellent technical assistance.

Funding Information

M.H. Schwab holds a Heisenberg Fellowship from Deutsche Forschungsgemeinschaft (DFG) and received funding by a DFG research grant (SCHW741/4-1).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that there is no conflict of interest.

References

  1. Alizadeh A, Dyck SM, Kataria H, Shahriary GM, Nguyen DH, Santhosh KT, Karimi-Abdolrezaee S (2017) Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia 65(7):1152–1175CrossRefGoogle Scholar
  2. Appel E, Kolman O, Kazimirsky G, Blumberg PM, Brodie C (1997) Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. Neuroreport 8:3309–3312CrossRefGoogle Scholar
  3. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574 LP–8578585CrossRefGoogle Scholar
  4. Bermingham-McDonogh O, McCabe KL, Reh TA (1996) Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development 122:1427 LP–1421438 Retrieved from http://dev.biologists.org/content/122/5/1427.abstract Google Scholar
  5. Blesch A, Tuszynski MH (2001) GDNF gene delivery to injured adult CNS motor neurons promotes axonal growth, expression of the trophic neuropeptide CGRP, and cellular protection. J Comp Neurol 436:399–410CrossRefGoogle Scholar
  6. Caggiula M, Batocchi AP, Frisullo G, Angelucci F, Patanella AK, Sancricca C, Mirabella M (2005) Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. Scand J Immunol 62:176–182.  https://doi.org/10.1111/j.1365-3083.2005.01649.x CrossRefPubMedGoogle Scholar
  7. Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, Bennett DLH (2010) Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci 30:5437–5450.  https://doi.org/10.1523/JNEUROSCI.5169-09.2010 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Cannella B, Pitt D, Marchionni M, Raine CS (1999) Neuregulin and erbB receptor expression in normal and diseased human white matter. J Neuroimmunol 100:233–242CrossRefGoogle Scholar
  9. Chao CC, Gekker G, Hu S, Peterson PK (1994) Human microglial cell defense against Toxoplasma gondii. The role of cytokines. Journal of Immunology (Baltimore, Md. : 1950) 152(3):1246–1252Google Scholar
  10. Chao CC, Hu SX, Ehrlich L, Peterson PK (1995) Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N-Methyl-D-aspartate receptors. Brain Behav Immun 9(4):355–365CrossRefGoogle Scholar
  11. Choi S, Friedman WJ (2009) Inflammatory cytokines IL-1 and TNF- regulate p75 expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms. ASN Neuro 1(2):AN20090009CrossRefGoogle Scholar
  12. Chu LF, Wang WT, Ghanta VK, Lin CH, Chiang YY, Hsueh CM (2008) Ischemic brain cell-derived conditioned medium protects astrocytes against ischemia through GDNF/ERK/NF-kB signaling pathway. Brain Res 1239:24–35.  https://doi.org/10.1016/j.brainres.2008.08.087 CrossRefPubMedGoogle Scholar
  13. Decker L, Picard-Riera N, Lachapelle F, Baron-Van Evercooren A (2002) Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination. J Neurosci Res 69:763–771.  https://doi.org/10.1002/jnr.10411 CrossRefPubMedGoogle Scholar
  14. Dimayuga FO, Ding Q, Keller JN, Marchionni MA, Seroogy KB, Bruce-Keller AJ (2003) The neuregulin GGF2 attenuates free radical release from activated microglial cells. J Neuroimmunol 136:67–74.  https://doi.org/10.1016/S0165-5728(03)00003-1 CrossRefPubMedGoogle Scholar
  15. Dityatev A, Dityateva G, Schachner M (2000) Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 26:207–217.  https://doi.org/10.1016/S0896-6273(00)81151-4 CrossRefPubMedGoogle Scholar
  16. Franklin RJM (2002) Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705–714.  https://doi.org/10.1038/nrn917 CrossRefPubMedGoogle Scholar
  17. Frota ERC, Rodrigues DH, Donadi EA, Brum DG, Maciel DRK, Teixeira AL (2009) Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neurosci Lett 460:130–132.  https://doi.org/10.1016/j.neulet.2009.05.057 CrossRefPubMedGoogle Scholar
  18. Furusho M, Roulois AJ, Franklin RJM, Bansal R (2015) Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions. Glia 63:1714–1728.  https://doi.org/10.1002/glia.22838 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Gerecke, K. M., Wyss, J. M., & Carroll, S. L. (2004). Neuregulin-1 B induces neurite extension and arborization in cultured hippocampal neurons, 27:379–393.  https://doi.org/10.1016/j.mcn.2004.08.001
  20. Gudi V, Škuljec J, Yildiz Ö, Frichert K, Skripuletz T, Moharregh-Khiabani D, Voß E, Wissel K, Wolter S, Stangel M (2011) Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS One 6:e22623.  https://doi.org/10.1371/journal.pone.0022623 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hashimoto M, Nitta A, Fukumitsu H, Nomoto H, Shen L, Furukawa S (2005) Involvement of glial cell line-derived neurotrophic factor in activation processes of rodent macrophages. J Neurosci Res 79:476–487.  https://doi.org/10.1002/jnr.20368 CrossRefPubMedGoogle Scholar
  22. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2006) Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84:1495–1504.  https://doi.org/10.1002/jnr.21056 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Huang Y, Smith DE, Ibanez-Sandoval O, Sims JE, Friedman WJ (2011) Neuron-specific effects of interleukin-1Â are mediated by a novel isoform of the IL-1 receptor accessory protein. Journal Neurosci 31(49):18048–18059CrossRefGoogle Scholar
  24. Huang XQ, Zhang XY, Wang XR, Yu SY, Fang SH, Lu YB, Zhang WP, Wei EQ (2012) Transforming growth factor Î21-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1. J Neuroinflammation 9(1):145CrossRefGoogle Scholar
  25. Ikeda T, Koo H, Xia YX, Ikenoue T, Choi BH (2002) Bimodal upregulation of glial cell line-derived neurotrophic factor (GDNF) in the neonatal rat brain following ischemic/hypoxic injury. Int J Dev Neurosci 20:555–562.  https://doi.org/10.1016/S0736-5748(02)00082-5 CrossRefPubMedGoogle Scholar
  26. Iravani MM, Sadeghian M, Leung CCM, Jenner P, Rose S (2012) Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor. Neurosci Lett 510:138–142.  https://doi.org/10.1016/j.neulet.2012.01.022 CrossRefPubMedGoogle Scholar
  27. Kataria H, Alizadeh A, Shahriary GM, Saboktakin Rizi S, Henrie R, Santhosh KT, Karimi-Abdolrezaee S (2018) Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord. Glia 66:538–561.  https://doi.org/10.1002/glia.23264 CrossRefPubMedGoogle Scholar
  28. König HG, Kögel D, Rami A, Prehn JHM (2005) TGF-beta1 activates two distinct type I receptors in neurons. J Cell Biol 168(7):1077–1086CrossRefGoogle Scholar
  29. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science (New York, N.Y.) 290(5492):767–773CrossRefGoogle Scholar
  30. Ku MC, Wolf SA, Respondek D, Matyash V, Pohlmann A, Waiczies S, Kettenmann H (2013) GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathol 125:609–620.  https://doi.org/10.1007/s00401-013-1079-8 CrossRefPubMedGoogle Scholar
  31. Kuno R, Yoshida Y, Nitta A, Nabeshima T, Wang J, Sonobe Y, Suzumura A (2006) The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res 1116:12–18.  https://doi.org/10.1016/j.brainres.2006.07.120 CrossRefPubMedGoogle Scholar
  32. Lee MS, Lee JO, Kang TW, Lee JH (1992) Transcription of class II MHC gene by interferon-gamma in FRTL-5 cells. J Korean Med Sci 7(3):189CrossRefGoogle Scholar
  33. Lee Y-J, Jin J-K, Jeong B-H, Carp RI, Kim Y-S (2006) Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice. Neurosci Lett 410:178–182.  https://doi.org/10.1016/j.neulet.2006.09.090 CrossRefPubMedGoogle Scholar
  34. Lin CH, Cheng FC, Lu YZ, Chu LF, Wang CH, Hsueh CM (2006) Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors. Exp Neurol 201(1):225–233Google Scholar
  35. Machado-Pereira M, Santos T, Ferreira L, Bernardino L, Ferreira R (2017) Anti-inflammatory strategy for M2 microglial polarization using retinoic acid-loaded nanoparticles. Mediat Inflamm 2017:1–11CrossRefGoogle Scholar
  36. McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, Kordower JH (2006) Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease. Proc Natl Acad Sci U S A 103:9345–9350.  https://doi.org/10.1073/pnas.0508875103 CrossRefPubMedPubMedCentralGoogle Scholar
  37. Meka DP, Müller-Rischart AK, Nidadavolu P, Mohammadi B, Motori E, Ponna SK, Kramer ER (2015) Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J Clin Invest 125:1873–1885.  https://doi.org/10.1172/JCI79300 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Miyazaki H, Nagashima K, Okuma Y, Nomura Y (2001) Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res 922:165–172.  https://doi.org/10.1016/s0006-8993(01)03013-x CrossRefPubMedGoogle Scholar
  39. Olajide OA, Bhatia HS, de Oliveira ACP, Wright CW, Fiebich BL (2013) Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine. Evid Based Complement Alternat Med 2013:1–10CrossRefGoogle Scholar
  40. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159–3167.  https://doi.org/10.1093/emboj/19.13.3159 CrossRefPubMedPubMedCentralGoogle Scholar
  41. Pearson RJJ, Carroll SL (2004) ErbB transmembrane tyrosine kinase receptors are expressed by sensory and motor neurons projecting into sciatic nerve. J Histochem Cytochem 52:1299–1311.  https://doi.org/10.1177/002215540405201006 CrossRefPubMedGoogle Scholar
  42. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC (1997) Differential production of and migratory response to  chemokines by human microglia and astrocytes. J Infect Dis 175(2):478–481CrossRefGoogle Scholar
  43. Pinkas-Kramarski R, Eilam R, Spiegler O, Lavi S, Liu N, Chang D, Wen D, Schwartz M, Yarden Y (1994) Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Natl Acad Sci U S A 91:9387–9391CrossRefGoogle Scholar
  44. Pollock GS, Franceschini IA, Graham G, Marchionni MA, Barnett SC (1999) Neuregulin is a mitogen and survival factor for olfactory bulb ensheathing cells and an isoform is produced by astrocytes. Eur J Neurosci 11:769–780CrossRefGoogle Scholar
  45. Prajeeth CK, Kronisch J, Khorooshi R, Knier B, Toft-Hansen H, Gudi V, Stangel M (2017) Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties. J Neuroinflammation 14:204.  https://doi.org/10.1186/s12974-017-0978-3 CrossRefPubMedPubMedCentralGoogle Scholar
  46. Qiao Y, Cong M, Li J, Li H, Li Z (2018) The effects of neuregulin-1β on intrafusal muscle fiber formation in neuromuscular coculture of dorsal root ganglion explants and skeletal muscle cells. Skelet Muscle 8:29.  https://doi.org/10.1186/s13395-018-0175-9 CrossRefPubMedPubMedCentralGoogle Scholar
  47. Rainone N, Chiodi A, Lanzillo R, Magri V, Napolitano A, Morra VB, Freda MF (2017) Affective disorders and health-related quality of life (HRQoL) in adolescents and young adults with multiple sclerosis (MS): the moderating role of resilience. Qual Life Res 26:727–736.  https://doi.org/10.1007/s11136-016-1466-4 CrossRefPubMedGoogle Scholar
  48. Razavi S, Nazem G, Mardani M, Esfandiari E, Salehi H, Esfahani SHZ (2015) Neurotrophic factors and their effects in the treatment of multiple sclerosis. Advanced Biomedical Research 4:53.  https://doi.org/10.4103/2277-9175.151570 CrossRefPubMedPubMedCentralGoogle Scholar
  49. Rickert U, Grampp S, Wilms H, Spreu J, Knerlich-Lukoschus F, Held-Feindt J, Lucius R (2014) Glial cell line-derived neurotrophic factor family members reduce microglial activation via inhibiting p38MAPKs-mediated inflammatory responses. J Neurodev Disord 2014:369–468.  https://doi.org/10.1155/2014/369468 CrossRefGoogle Scholar
  50. Rocha SM, Cristovão AC, Campos FL, Fonseca CP, Baltazar G (2012) Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol Dis 47:407–415.  https://doi.org/10.1016/j.nbd.2012.04.014 CrossRefPubMedGoogle Scholar
  51. Salimi K, Moser KV, Marksteiner J, Reindl M, Humpel C (2003) GDNF and TGF-beta1 promote cell survival in serum-free cultures of primary rat microglia. Cell Tissue Res 312:135–139.  https://doi.org/10.1007/s00441-003-0711-7 CrossRefPubMedGoogle Scholar
  52. Sama MA, Mathis DM, Furman JL, Abdul HM, Artiushin IA, Kraner SD, Norris CM (2008) Interleukin-1Î2-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 283(32):21953–21964CrossRefGoogle Scholar
  53. Sariola H, Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci 116:3855–3862.  https://doi.org/10.1242/jcs.00786 CrossRefPubMedGoogle Scholar
  54. Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, Adachi K, Kiuchi K (2000) Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. Neuroreport 11:3877–3881CrossRefGoogle Scholar
  55. Sheng WS, Hu S, Kravitz FH, Peterson PK, Chao CC (1995) Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro. Clin Diagn Lab Immunol 2(5):604–608PubMedPubMedCentralGoogle Scholar
  56. Stassart RM, Fledrich R, Velanac V, Brinkmann BG, Schwab MH, Meijer D, Nave K-A (2013) A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci 16:48. Retrieved from–54.  https://doi.org/10.1038/nn.3281
  57. Strokin M, Sergeeva M, Reiser G (2011) Proinflammatory treatment of astrocytes with lipopolysaccharide results in augmented Ca signaling through increased expression of VIA phospholipase A (iPLA ). American Journal of Physiology-Cell Physiology 300(3):C542–C549CrossRefGoogle Scholar
  58. Tanaka T, Oh-hashi K, Shitara H, Hirata Y, Kiuchi K (2007) NF-κB independent signaling pathway is responsible for LPS-induced GDNF gene expression in primary rat glial cultures. Neurosci Lett 431:262–267.  https://doi.org/10.1016/j.neulet.2007.11.051 CrossRefPubMedGoogle Scholar
  59. Trok K, Hoffer B, Olsen L (1996) Glial cell line-derived neurotrophic factor enhances survival and growth of presental and postnatal spinal cold transplant. Neuroscience 71:231–241CrossRefGoogle Scholar
  60. van Neerven S, Nemes A, Imholz P, Regen T, Denecke B, Johann S, Beyer C, Hanisch UK, Mey J (2010) Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J Neuroimmunol 229(1-2):169–179CrossRefGoogle Scholar
  61. Wang L-J, Lu Y-Y, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Nakano I (2002) Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22:6920–6928 20026668 CrossRefGoogle Scholar
  62. Webster HD (1997) Growth factors and myelin regeneration in multiple sclerosis. Multiple Scler 3:113–120.  https://doi.org/10.1177/135245859700300210 CrossRefGoogle Scholar
  63. Wostradowski T, Prajeeth CK, Gudi V, Kronenberg J, Witte S, Brieskorn M, Stangel M (2016) In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia. J Neuroinflammation 13(1):250CrossRefGoogle Scholar
  64. Xing B, Xin T, Zhao L, Hunter RL, Chen Y, Bing G (2010) Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity. J Neuroimmunol 225:43–51.  https://doi.org/10.1016/j.jneuroim.2010.04.010 CrossRefPubMedPubMedCentralGoogle Scholar
  65. Yu ACH, Liu RY, Zhang Y, Sun HR, Qin LY, Lau LT, Han JS (2007) Glial cell line-derived neurotrophic factor protects astrocytes from staurosporine- and ischemia- induced apoptosis. J Neurosci Res 85:3457–3464.  https://doi.org/10.1002/jnr.21345 CrossRefPubMedGoogle Scholar
  66. Zhang L, Ma Z, Smith GM, Wen X, Pressman Y, Wood PM, Xu X-M (2009) GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 57:1178–1191.  https://doi.org/10.1002/glia.20840 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Clinical Neuroimmunology and Neurochemistry, Department of NeurologyHannover Medical SchoolHannoverGermany
  2. 2.Center for Systems NeuroscienceUniversity of Veterinary Medicine HannoverHannoverGermany
  3. 3.Cellular Neurophysiology, Center of PhysiologyHannover Medical SchoolHannoverGermany

Personalised recommendations